Literature DB >> 22513348

Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene.

Urh Groselj1, Mojca Zerjav Tansek, Jernej Kovac, Tinka Hovnik, Katarina Trebusak Podkrajsek, Tadej Battelino.   

Abstract

Mutational spectrum of the phenylalanine hydroxylase (PAH) deficiency was investigated in 107 families (90% of the Slovene PKU population). The entire coding region of the PAH gene was analyzed with dHPLC to select the samples where subsequently the automated sequencing analysis was performed. MLPA analysis was performed to identify large deletions, which were later confirmed with long-range PCR. Correlations with patients' phenotypes and genotype-based predictions of BH(4)-responsiveness were assessed. Altogether, disease-causing mutations were identified on 209 alleles (detection rate 97.7%). A spectrum of 36 different disease-causing mutations was identified: 20 missense mutations (80% of the alleles), eight splicing mutations (13% of the alleles), one nonsense mutation (0.5% of the alleles), four small deletions with frame shift (6% of the alleles), one small insertion with frame shift (0.5% of the alleles), and two large deletions (2% of the alleles). The most frequent mutation was p.R408W in exon 12, representing 29% of the alleles, which is in concordance with other neighboring and/or Slavic PKU populations. Other common mutations were: p.R158Q, p.A403V, p.P281L and p.E390G, accounting for 9%, 7%, 7% and 7% of the alleles respectively. Five novel mutations were detected: c.43_44insAG, c.56_59+1delACAGG, p.V45A, p.L62P and p.R157S. Large deletion of exon 5 (EX5del955) was found in three patients and a deletion of exon 3 (EX3del4765) in one patient. A spectrum of 64 different genotypes was found, seven of them accounting for over than a third of all families. Among thirteen families with homozygous mutation (13% of the PKU population), 10 had p.R408W, two had p.R158Q and one had p.E390G. Among 107 families, 58 were classified as classic PKU (54.2%), 28 as mild PKU (25.9%) and 21 as MHP (19.6%). Twenty-six different genotypes (40.6%) were predicted to be BH(4)-responsive, represented by 38 different families (35.5%).
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513348     DOI: 10.1016/j.ymgme.2012.03.015

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Molecular Genetics and Genotype-Based Estimation of BH4-Responsiveness in Serbian PKU Patients: Spotlight on Phenotypic Implications of p.L48S.

Authors:  Maja Djordjevic; Kristel Klaassen; Adrijan Sarajlija; Natasa Tosic; Branka Zukic; Bozica Kecman; Milena Ugrin; Vesna Spasovski; Sonja Pavlovic; Maja Stojiljkovic
Journal:  JIMD Rep       Date:  2012-10-13

2.  The IVS8-2A>G (c.913-2A>G) mutation and the PAH deficiency populations of Central Europe.

Authors:  Urh Groselj; Mojca Zerjav Tansek; Katarina Trebusak Podkrajsek; Tadej Battelino
Journal:  J Inherit Metab Dis       Date:  2012-11-16       Impact factor: 4.982

3.  Mutational spectrum of phenylketonuria in Jiangsu province.

Authors:  Ya-fen Chen; Hai-tao Jia; Zhong-hai Chen; Jia-ping Song; Yu Liang; Jing-jing Pei; Zhi-jun Wu; Jing Wang; Ya-li Qiu; Gang Liu; Dong-mei Sun; Xin-ye Jiang
Journal:  Eur J Pediatr       Date:  2015-04-19       Impact factor: 3.183

4.  Phenylketonuria screening and management in southeastern Europe - survey results from 11 countries.

Authors:  Mojca Zerjav Tansek; Urh Groselj; Natalija Angelkova; Dana Anton; Ivo Baric; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Miljanovic; Florentina Moldovanu; Mariana Muresan; Michaela Nanu; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

Review 5.  International regulatory landscape and integration of corrective genome editing into in vitro fertilization.

Authors:  Motoko Araki; Tetsuya Ishii
Journal:  Reprod Biol Endocrinol       Date:  2014-11-24       Impact factor: 5.211

6.  Fifty-Five Years of Pediatric Endocrinology and 50 Years of the Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases in Slovenia.

Authors:  Tadej Battelino
Journal:  Zdr Varst       Date:  2015-03-13

7.  First Case Report of EX3del4765 Mutation in PAH Gene in Asian Population.

Authors:  Ziba Soltani; Fatemeh Karami; Vahidreza Yassaee; Feyzollah Hashemi Gorji; Mahdieh Talebzadeh; Mohammad Miryounesi
Journal:  Iran Red Crescent Med J       Date:  2016-01-01       Impact factor: 0.611

8.  Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.

Authors:  Polina Gundorova; Anna A Stepanova; Irina A Kuznetsova; Sergey I Kutsev; Aleksander V Polyakov
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

9.  Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.

Authors:  Nana Li; Haitao Jia; Zhen Liu; Jing Tao; Song Chen; Xiaohong Li; Ying Deng; Xi Jin; Jiaping Song; Liangtao Zhang; Yu Liang; Wei Wang; Jun Zhu
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

10.  Analysis of EX5del4232ins268 and EX5del955 PAH gene mutations in Ukrainian patients with phenylketonuria.

Authors:  Volodymyr Pampukha; Maryna Nechyporenko; Ludmila Livshyts
Journal:  Genes Dis       Date:  2016-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.